Cover image of the article: Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication

Image Credit:Zahedan J Res Med Sci

Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication

Authors

Vahid Mirzaei1,*, omid rezahosseini2
1Department of Gastroenterology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2Medical Student, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
*Corresponding Author: Department of Gastroenterology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran Email: vah_mirzaee@yahoo.com

Zahedan Journal of Research in Medical Sciences:Vol. 15, issue 4; e92995
Published online:Nov 05, 2012
Article type:Research Article
Received:Feb 19, 2012
Accepted:May 05, 2012
How to Cite:Mirzaei V, rezahosseini O. Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication. Zahedan J Res Med Sci. 2013;15(4):e92995. doi:

Abstract

Background : Treatment of Helicobacter pylori as a major cause of gastric diseases is of utmost concern. We aimed to assess efficacy of triple therapy (amoxicillin, clarithromycin and pantoprazole) plus probiotic yogurt (PY) on eradication of H. pylori.
Materials and Methods : Total 102 H. pylori positive patients were divided to 3 groups equally and randomly. For treatment of each group amoxicillin, clarithromycin and pantoprazole were used. Group A had additional PY and Group B ordinary low fat yogurt in their regimen as well. These groups were compared regarding treatment success.
Results : Total number of 88 patients finished the treatment course. The most common experienced side effects were dysgeusia in groups A and B (25.8% and 32.3%, respectively), and dysgeusia with diarrhea and abdominal pain (30.8%) in group C. Eradication rate was, respectively, 61.3%, 64.5%  and 71.3% in group A, B and C of which difference was not statistically significant. However, the difference between 3 groups in regard to education level was statistically significant (p=0.005).
Conclusion : PY enriched triple therapy has decreased side effects of antibiotics consumption however, this has no impact on eradication of H. pylori. PY and triple therapy can be used concomitantly to increase the patient tolerance.

Highlights

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

12
Dec
2023
The Effect of Quadruple Therapy Plus Probiotics on Helicobacter Pylori Eradication and Antibiotic-Associated Side Effects: A Randomized Placebo-Controlled Trial

The Effect of Quadruple Therapy Plus Probiotics on Helicobacter Pylori Eradication and Antibiotic-Associated Side Effects: A Randomized Placebo-Controlled Trial

Yazdan Hamzavi,
Homayoon Bashiri

Hamzavi Y, Bashiri H. The Effect of Quadruple Therapy Plus Probiotics on Helicobacter Pylori Eradication and Antibiotic-Associated Side Effects: A Randomized Placebo-Controlled Trial. J Kermanshah Univ Med Sci. 2023;27(4):e137908. doi: https://doi.org/10.5812/jkums-137908

2
Jan
2013
Probiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial

Probiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial

Ahmad Khodadad,
Fatemeh Farahmand,
Mehri Najafi,
Maryam Shoaran

Khodadad A, Farahmand F, Najafi M, Shoaran M. Probiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial. Inn J Pediatr. 2013;23(1):. doi:

9
Feb
2021
Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection

Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection

Alireza Bakhshipour,
Narges Mohsenpour Mohammadi,
Seyed Mahdi Hashemi,
Mohammad Kazem Momeni

Bakhshipour A, Mohsenpour Mohammadi N, Hashemi SM, Momeni MK. Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection. Int J Infect. 2021;8(1):e98954. doi: https://doi.org/10.5812/iji.98954

30
Nov
2008
COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN

COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN

E Hajiani,
J Hashemi,
T Vosoghi

Hajiani E, Hashemi J, Vosoghi T. COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN. Jundishapur J Nat Pharm Prod. 2008;3(1):. doi:

1
Oct
2012
Prospective Randomized Trial of Esomeprazole versus Lansoprazole and Omeprazole Based Triple Therapy for H. Pylori Eradication in an Iranian Population

Prospective Randomized Trial of Esomeprazole versus Lansoprazole and Omeprazole Based Triple Therapy for H. Pylori Eradication in an Iranian Population

Abdol Rahim Masjedizadeh,
Eskandar Hajiani,
Jalal Hashemi,
Ali Akbar Shayesteh,
Somieh Sadrneshin

Masjedizadeh AR, Hajiani E, Hashemi J, Shayesteh AA, Sadrneshin S. Prospective Randomized Trial of Esomeprazole versus Lansoprazole and Omeprazole Based Triple Therapy for H. Pylori Eradication in an Iranian Population. Shiraz E-Med J. 2012;13(4):. doi:

More by these authors

Vahid MirzaeiPubMedScholar
omid rezahosseiniPubMedScholar
Share
Cited by
Metrics